21st Century to price IPO of 13,333,333 shares between $14.00, $16.00

Morgan Stanley, JPMorgan and Wells Fargo are the joint bookrunners

By Devika Patel

Knoxville, Tenn., May 16 - 21st Century Oncology Holdings, Inc. will sell 13,333,333 common shares in its initial public offering with a 30-day greenshoe of 2 million additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Feb. 11.

The shares will be sold at a price expected to fall between $14.00 and $16.00 per share.

Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are the joint bookrunning managers. SunTrust Robinson Humphrey Inc., KeyBanc Capital Markets Inc., Avondale Partners, LLC and Piper Jaffray & Co. are the co-managers.

The company also plans to offer 1.5 million series A mandatory convertible junior non-voting preferred shares in a concurrent public offering with a 30-day option to purchase an additional 225,000 preferreds.

Proceeds will be used to repay debt and for general corporate purposes.

The Fort Meyers, Fla., company offers cancer treatment services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.